BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9002223)

  • 1. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.
    O'Reilly MS; Holmgren L; Shing Y; Chen C; Rosenthal RA; Moses M; Lane WS; Cao Y; Sage EH; Folkman J
    Cell; 1994 Oct; 79(2):315-28. PubMed ID: 7525077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
    Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
    Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiostatin. A biological inhibitor of tumor angiogenesis].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
    Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
    Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor growth with recombinant murine angiostatin.
    Wu Z; O'Reilly MS; Folkman J; Shing Y
    Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; LlinĂ¡s M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
    Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial progenitor cells as putative targets for angiostatin.
    Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
    Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatin.
    Cao Y; Xue L
    Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL; Stack MS; Wahl ML; Pizzo SV
    Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
    Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
    Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
    Drixler TA; Borel Rinkes IH; Ritchie ED; van Vroonhoven TJ; Gebbink MF; Voest EE
    Cancer Res; 2000 Mar; 60(6):1761-5. PubMed ID: 10749151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.